{"component": "contracts", "props": {"contracts": [{"intro": "", "id": "fa06mSs3xri", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000115752306010220/a5257389ex99_1.txt", "category_name": "Employment Agreement", "company_name": "Gene Logic Inc", "created": "October 24th, 2006", "published": true, "pretty": null, "uri": "/contracts/fa06mSs3xri", "title": "Exhibit 99.1", "group_id": "30OMrHdAp1n", "group_samples": [{"label": "Employment Agreement (Payless Cashways Inc)", "uri": "/contracts/6ccJaJbYKAv", "published": true}, {"label": "Employment Agreement (Gene Logic Inc)", "uri": "/contracts/fa06mSs3xri", "published": true}, {"label": "Employment Agreement (Bottomline Technologies Inc /De/)", "uri": "/contracts/9g9myNhwGyC", "published": true}], "group_size": 5, "tags": [{"name": "Employment Agreement", "type": "category", "uri": "/contracts/tagged/employment-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}]}, {"intro": "", "id": "69Z86aSm6hv", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000091205797032791/7.txt", "category_name": "Stock Option Agreement", "company_name": "Gene Logic Inc", "created": "October 7th, 1997", "published": true, "pretty": null, "uri": "/contracts/69Z86aSm6hv", "title": "Exhibit 10.3 GENE LOGIC INC. 1997 EQUITY INCENTIVE PLAN", "group_id": "69Z86aSm6hv", "group_samples": [{"label": "Stock Option Agreement (Javelin Systems Inc)", "uri": "/contracts/9jLZScJIoNH", "published": true}, {"label": "Stock Option Agreement (Gene Logic Inc)", "uri": "/contracts/69Z86aSm6hv", "published": true}, {"label": "Stock Option Agreement (Gladstone Capital Corp)", "uri": "/contracts/8izH4oAuHTf", "published": true}], "group_size": 5, "tags": [{"name": "Stock Option Agreement", "type": "category", "uri": "/contracts/tagged/stock-option-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}]}, {"intro": "", "id": "gIP5hz9DmMI", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000104746998026942/5.txt", "category_name": "Convertible Preferred Stock Purchase Agreement", "company_name": "Gene Logic Inc", "created": "July 10th, 1998", "published": true, "pretty": null, "uri": "/contracts/gIP5hz9DmMI", "title": "July 6, 1998", "group_id": "1WUtrou9f6d", "group_samples": [{"label": "Convertible Preferred Stock Purchase Agreement (Pipeline Technologies Inc)", "uri": "/contracts/jELPVCdjYbl", "published": true}, {"label": "Convertible Preferred Stock Purchase Agreement (Able Telcom Holding Corp)", "uri": "/contracts/1WUtrou9f6d", "published": true}, {"label": "Convertible Preferred Stock Purchase Agreement (Mapics Inc)", "uri": "/contracts/6Ht4Y95wfLn", "published": true}], "group_size": 4, "tags": [{"name": "Convertible Preferred Stock Purchase Agreement", "type": "category", "uri": "/contracts/tagged/convertible-preferred-stock-purchase-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "Services-commercial physical & biological research", "type": "industry", "uri": "/contracts/tagged/services-commercial-physical-biological-research"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "", "id": "i61mnCZMDjr", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000095013301500318/w46553ex10-68.txt", "category_name": "Employment Agreement", "company_name": "Gene Logic Inc", "created": "March 29th, 2001", "published": true, "pretty": null, "uri": "/contracts/i61mnCZMDjr", "title": "RECITAL:", "group_id": "7NKOqU4N0lw", "group_samples": [{"label": "Employment Agreement (Gene Logic Inc)", "uri": "/contracts/dGZVkl9mRNf", "published": true}, {"label": "Employment Agreement (Gene Logic Inc)", "uri": "/contracts/jBDkogVpJxt", "published": true}, {"label": "Employment Agreement (Gene Logic Inc)", "uri": "/contracts/7NKOqU4N0lw", "published": true}], "group_size": 4, "tags": [{"name": "Employment Agreement", "type": "category", "uri": "/contracts/tagged/employment-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "Services-commercial physical & biological research", "type": "industry", "uri": "/contracts/tagged/services-commercial-physical-biological-research"}]}, {"intro": "", "id": "9vVEGmlvE7i", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000091205797032791/30.txt", "category_name": "License Agreement", "company_name": "Gene Logic Inc", "created": "October 7th, 1997", "published": true, "pretty": null, "uri": "/contracts/9vVEGmlvE7i", "title": "LICENSE AGREEMENT AGREEMENT effective on the date of the last signature hereon, by and between YALE UNIVERSITY, a corporation organized and existing under and by virtue of a charter granted by the general assembly of the Colony and State of...", "group_id": "kOsii6o8eRf", "group_samples": [{"label": "License Agreement (Scolr Inc)", "uri": "/contracts/dwNDeqzhKTp", "published": true}, {"label": "License Agreement (Amicus Therapeutics Inc)", "uri": "/contracts/kOsii6o8eRf", "published": true}, {"label": "License Agreement (Gene Logic Inc)", "uri": "/contracts/9vVEGmlvE7i", "published": true}], "group_size": 3, "tags": [{"name": "License Agreement", "type": "category", "uri": "/contracts/tagged/license-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "Connecticut", "type": "jurisdiction", "uri": "/contracts/tagged/connecticut-us"}]}, {"intro": "", "id": "1C2gsCKDzXY", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000104746997005578/1.txt", "category_name": "Target Discovery Collaboration and License Agreement", "company_name": "Gene Logic Inc", "created": "November 20th, 1997", "published": true, "pretty": null, "uri": "/contracts/1C2gsCKDzXY", "title": "TARGET DISCOVERY COLLABORATION AND LICENSE AGREEMENT BETWEEN GENE LOGIC INC. AND PROCTER & GAMBLE PHARMACEUTICALS, INC.", "group_id": "1C2gsCKDzXY", "group_samples": [{"label": "Target Discovery Collaboration and License Agreement (Gene Logic Inc)", "uri": "/contracts/1C2gsCKDzXY", "published": true}, {"label": "Target Discovery Collaboration and License Agreement (Gene Logic Inc)", "uri": "/contracts/g3ktxVCtqkW", "published": true}], "group_size": 2, "tags": [{"name": "Target Discovery Collaboration and License Agreement", "type": "category", "uri": "/contracts/tagged/target-discovery-collaboration-and-license-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "Services-commercial physical & biological research", "type": "industry", "uri": "/contracts/tagged/services-commercial-physical-biological-research"}, {"name": "Delaware", "type": "jurisdiction", "uri": "/contracts/tagged/delaware-us"}]}, {"intro": "", "id": "1g1Z8j9W3W7", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000091205797032791/12.txt", "category_name": "Stock Restriction Agreement", "company_name": "Gene Logic Inc", "created": "October 7th, 1997", "published": true, "pretty": null, "uri": "/contracts/1g1Z8j9W3W7", "title": "Exhibit 10.8 GENE LOGIC INC.", "group_id": "1g1Z8j9W3W7", "group_samples": [{"label": "Stock Restriction Agreement (Gene Logic Inc)", "uri": "/contracts/4QeVGraaIxc", "published": true}, {"label": "Stock Restriction Agreement (Gene Logic Inc)", "uri": "/contracts/1g1Z8j9W3W7", "published": true}], "group_size": 2, "tags": [{"name": "Stock Restriction Agreement", "type": "category", "uri": "/contracts/tagged/stock-restriction-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "Delaware", "type": "jurisdiction", "uri": "/contracts/tagged/delaware-us"}]}, {"intro": "This LICENSE AGREEMENT (the \u201cAgreement\u201d) is entered into and effective as of December 14, 2007 (the \u201cEffective Date\u201d), by and between Gene Logic Inc. (\u201cLicensee\u201d), a Delaware corporation, with a principal address at 50 West Watkins Mill Road", "id": "5MXzrzaabEM", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000115752307012272/a5570624ex_10100.htm", "category_name": "License Agreement", "company_name": "Gene Logic Inc", "created": "December 18th, 2007", "published": true, "pretty": null, "uri": "/contracts/5MXzrzaabEM", "title": "LICENSE AGREEMENT DRUG REPOSITIONING BUSINESS", "group_id": "5MXzrzaabEM", "group_samples": [{"label": "License Agreement (Gene Logic Inc)", "uri": "/contracts/5MXzrzaabEM", "published": true}, {"label": "License Agreement (Gene Logic Inc)", "uri": "/contracts/exuxE5eXWFN", "published": true}], "group_size": 2, "tags": [{"name": "License Agreement", "type": "category", "uri": "/contracts/tagged/license-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Maryland", "type": "jurisdiction", "uri": "/contracts/tagged/maryland-us"}]}, {"intro": "", "id": "9HELYVQNRln", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000095013300003427/ex10-64.txt", "category_name": "Genomic Database Collaboration and License Agreement", "company_name": "Gene Logic Inc", "created": "August 14th, 2000", "published": true, "pretty": null, "uri": "/contracts/9HELYVQNRln", "title": "EXHIBIT 10.64 FIRST AMENDMENT TO THE GENOMIC DATABASE COLLABORATION AND LICENSE AGREEMENT Dear Mr. Gessler: This letter will serve as an amendment to the Genomic Database Collaboration and License Agreement (\"Agreement\"), dated December 30, 1998,...", "group_id": "9HELYVQNRln", "group_samples": [{"label": "Genomic Database Collaboration and License Agreement (Gene Logic Inc)", "uri": "/contracts/hIhTU4zEFrI", "published": true}, {"label": "Genomic Database Collaboration and License Agreement (Gene Logic Inc)", "uri": "/contracts/9HELYVQNRln", "published": true}], "group_size": 2, "tags": [{"name": "Genomic Database Collaboration and License Agreement", "type": "category", "uri": "/contracts/tagged/genomic-database-collaboration-and-license-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "Services-commercial physical & biological research", "type": "industry", "uri": "/contracts/tagged/services-commercial-physical-biological-research"}]}, {"intro": "", "id": "fDUKhEsfbNU", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000095013304000938/w95058exv10w78.txt", "category_name": "Settlement and Nonexclusive License Agreement", "company_name": "Gene Logic Inc", "created": "March 15th, 2004", "published": true, "pretty": null, "uri": "/contracts/fDUKhEsfbNU", "title": "WITNESSETH", "group_id": "fDUKhEsfbNU", "group_samples": [{"label": "Settlement and Nonexclusive License Agreement (Gene Logic Inc)", "uri": "/contracts/fDUKhEsfbNU", "published": true}, {"label": "Settlement and Nonexclusive License Agreement (Gene Logic Inc)", "uri": "/contracts/ksEy56ja0Xa", "published": true}], "group_size": 2, "tags": [{"name": "Settlement and Nonexclusive License Agreement", "type": "category", "uri": "/contracts/tagged/settlement-and-nonexclusive-license-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "California", "type": "jurisdiction", "uri": "/contracts/tagged/california-us"}]}, {"intro": "FOR V ALUE RECEIVED, and in consideration for, and as an inducement to Oxbridge Development at Crown Pointe, L.C., a Maryland limited liability company, to consent to an assignment by merger of the lease for space at 610 Professional Drive, Gaithersburg, Md. 20879 dated as of June 22, 2001, as amended September 25, 2001 and as further amended in January, 2003 (such amendment being signed by Joseph Angle on behalf of the then tenant on January 21, 2003 and last initialed by Landlord on January 24, 2003) (the \"Lease\"), in which it is \"Landlord\" to GLA II Corp., a Delaware corporation (to be renamed TherImmune Research Corporation at the time of the merger) (\u201cTenant\"), a wholly-owned subsidiary of the undersigned and successor in interest by merger to TherImmune Research Corporation, a Maryland corporation, the original tenant under the Lease, the undersigned, whether one or more, jointly and severally do hereby unconditionally guarantee to Landlord (i)l the punctual and full payment of a", "id": "gpzQixT6JNt", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000115752307004994/a5398525ex10_80a.htm", "category_name": "Guaranty of Lease", "company_name": "Gene Logic Inc", "created": "May 10th, 2007", "published": true, "pretty": null, "uri": "/contracts/gpzQixT6JNt", "title": "GUARANTY OF LEASE", "group_id": "gpzQixT6JNt", "group_samples": [{"label": "Guaranty of Lease (Gene Logic Inc)", "uri": "/contracts/gpzQixT6JNt", "published": true}, {"label": "Guaranty of Lease (Gene Logic Inc)", "uri": "/contracts/hrbrS4KNzsj", "published": true}], "group_size": 2, "tags": [{"name": "Guaranty of Lease", "type": "category", "uri": "/contracts/tagged/guaranty-of-lease"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}]}, {"intro": "This Stock Purchase Agreement (this \u201cAgreement\u201d), is made and entered into as of September 19, 2008, by and between Nerveda, Inc., a Delaware corporation (the \u201cPurchaser\u201d) and Ore Pharmaceuticals Inc., a Delaware corporation (the \u201cSeller\u201d). Certain capitalized terms in this Agreement have the meanings ascribed thereto in Section 1.1.", "id": "klVYFaF2BFL", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000115752308007543/a5783915ex10104.htm", "category_name": "Stock Purchase Agreement", "company_name": "Gene Logic Inc", "created": "September 23rd, 2008", "published": true, "pretty": null, "uri": "/contracts/klVYFaF2BFL", "title": "STOCK PURCHASE AGREEMENT by and between NERVEDA, INC. and ORE PHARMACEUTICALS INC. Dated as of September 19, 2008", "group_id": "gxXjqTBXEyl", "group_samples": [{"label": "Stock Purchase Agreement (Gene Logic Inc)", "uri": "/contracts/klVYFaF2BFL", "published": true}, {"label": "Stock Purchase Agreement (Planar Systems Inc)", "uri": "/contracts/gxXjqTBXEyl", "published": true}], "group_size": 2, "tags": [{"name": "Stock Purchase Agreement", "type": "category", "uri": "/contracts/tagged/stock-purchase-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Delaware", "type": "jurisdiction", "uri": "/contracts/tagged/delaware-us"}]}, {"intro": "", "id": "jVv7ZxUY0Jm", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000095013399003615/3.txt", "category_name": "Drug Target and Drug Lead Discovery Collaboration Agreement", "company_name": "Gene Logic Inc", "created": "November 15th, 1999", "published": true, "pretty": null, "uri": "/contracts/jVv7ZxUY0Jm", "title": "1 EXHIBIT 10.57 CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTIONS 200.800(b)(4), 200.83 and 240.24b-2 [GENE LOGIC LETTERHEAD] September 28, 1999 Mr. K. Kiyose Japan Tobacco Inc. Pharmaceutical Division JT Building 2-1, Toranomon 2-chome...", "group_id": "ihWfc9nH1gb", "group_samples": [{"label": "Drug Target and Drug Lead Discovery Collaboration Agreement (Gene Logic Inc)", "uri": "/contracts/jVv7ZxUY0Jm", "published": true}, {"label": "Drug Target and Drug Lead Discovery Collaboration Agreement (Gene Logic Inc)", "uri": "/contracts/ihWfc9nH1gb", "published": true}], "group_size": 2, "tags": [{"name": "Drug Target and Drug Lead Discovery Collaboration Agreement", "type": "category", "uri": "/contracts/tagged/drug-target-and-drug-lead-discovery-collaboration-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "Services-commercial physical & biological research", "type": "industry", "uri": "/contracts/tagged/services-commercial-physical-biological-research"}]}, {"intro": "This Second Amendment (the \u201cAmendment\u201d) is made on this 8th day of May, 2007, but as of the 23rd day of February, 2007 by and between Gene Logic Inc., a Delaware corporation (the \u201cCompany\u201d), and Philip L. Rohrer, Jr. (the \u201cExecutive\u201d).", "id": "1f1qsVpvd4H", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000115752307004994/a5398525ex10_58a.htm", "category_name": "Executive Employment Agreement", "company_name": "Gene Logic Inc", "created": "May 10th, 2007", "published": true, "pretty": null, "uri": "/contracts/1f1qsVpvd4H", "title": "Second Amendment to Executive Employment Agreement", "group_id": "1f1qsVpvd4H", "group_samples": [{"label": "Executive Employment Agreement (Gene Logic Inc)", "uri": "/contracts/1f1qsVpvd4H", "published": true}], "group_size": 1, "tags": [{"name": "Executive Employment Agreement", "type": "category", "uri": "/contracts/tagged/executive-employment-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}]}, {"intro": "", "id": "2BZAZWfOF8u", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000095013399003615/2.txt", "category_name": "Genomic Database Collaboration and License Agreement", "company_name": "Gene Logic Inc", "created": "November 15th, 1999", "published": true, "pretty": null, "uri": "/contracts/2BZAZWfOF8u", "title": "AGREEMENT", "group_id": "2BZAZWfOF8u", "group_samples": [{"label": "Genomic Database Collaboration and License Agreement (Gene Logic Inc)", "uri": "/contracts/2BZAZWfOF8u", "published": true}], "group_size": 1, "tags": [{"name": "Genomic Database Collaboration and License Agreement", "type": "category", "uri": "/contracts/tagged/genomic-database-collaboration-and-license-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "Services-commercial physical & biological research", "type": "industry", "uri": "/contracts/tagged/services-commercial-physical-biological-research"}, {"name": "Maryland", "type": "jurisdiction", "uri": "/contracts/tagged/maryland-us"}]}, {"intro": "THIS Agreement (\u201cAgreement\u201d), effective June 18, 2001 is entered into by and between Gene Logic Inc. (\u201cGLGC\u201d), whose place of business is at 708 Quince Orchard Road, Gaithersburg, Maryland 20878, and J. Stark Thompson, whose address is: 207 Walnut Ridge Lane, Chadds Ford, Pennsylvania 19317 (\u201cConsultant\u201d).", "id": "3e2Q97X6KRQ", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000095013302001254/w58282ex10-74.htm", "category_name": "Consulting Services Agreement", "company_name": "Gene Logic Inc", "created": "March 28th, 2002", "published": true, "pretty": null, "uri": "/contracts/3e2Q97X6KRQ", "title": "CONSULTING SERVICES AGREEMENT", "group_id": "3e2Q97X6KRQ", "group_samples": [{"label": "Consulting Services Agreement (Gene Logic Inc)", "uri": "/contracts/3e2Q97X6KRQ", "published": true}], "group_size": 1, "tags": [{"name": "Consulting Services Agreement", "type": "category", "uri": "/contracts/tagged/consulting-services-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Maryland", "type": "jurisdiction", "uri": "/contracts/tagged/maryland-us"}]}, {"intro": "THIS EMPLOYMENT AGREEMENT (the \u201cAgreement\u201d) is entered into as of the 31st day of December, 2008 by and between Ore Pharmaceuticals Inc., a Delaware corporation (the \u201cCompany\u201d), and Philip L. Rohrer, Jr. (the \u201cExecutive\u201d).", "id": "4I4aqDBVJeS", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000115752309000277/a5872515ex10-58c.htm", "category_name": "Executive Employment Agreement", "company_name": "Gene Logic Inc", "created": "January 15th, 2009", "published": true, "pretty": null, "uri": "/contracts/4I4aqDBVJeS", "title": "EXECUTIVE EMPLOYMENT AGREEMENT", "group_id": "4I4aqDBVJeS", "group_samples": [{"label": "Executive Employment Agreement (Gene Logic Inc)", "uri": "/contracts/4I4aqDBVJeS", "published": true}], "group_size": 1, "tags": [{"name": "Executive Employment Agreement", "type": "category", "uri": "/contracts/tagged/executive-employment-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Maryland", "type": "jurisdiction", "uri": "/contracts/tagged/maryland-us"}]}, {"intro": "THIS EMPLOYMENT AGREEMENT (the \u201cAgreement\u201d) is entered into as of the 2nd day of July, 2003, by and between Gene Logic Inc., a Delaware corporation (the \u201cCompany\u201d), and Robert Proulx (the \u201cExecutive\u201d).", "id": "4teeeCZB4jK", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000095013303003887/w91593exv10w82.htm", "category_name": "Employment Agreement", "company_name": "Gene Logic Inc", "created": "November 13th, 2003", "published": true, "pretty": null, "uri": "/contracts/4teeeCZB4jK", "title": "EMPLOYMENT AGREEMENT", "group_id": "4teeeCZB4jK", "group_samples": [{"label": "Employment Agreement (Gene Logic Inc)", "uri": "/contracts/4teeeCZB4jK", "published": true}], "group_size": 1, "tags": [{"name": "Employment Agreement", "type": "category", "uri": "/contracts/tagged/employment-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Maryland", "type": "jurisdiction", "uri": "/contracts/tagged/maryland-us"}]}, {"intro": "THIS EMPLOYMENT AGREEMENT (the \u201cAgreement\u201d) is made and entered into as of May 30, 2002 by and between GENE LOGIC INC., a Delaware corporation (the \u201cCompany\u201d) and DUDLEY STAPLES, a Maryland resident (\u201cSTAPLES\u201d).", "id": "52NWcFzkv9l", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000095013302002833/w62928exv10w75.htm", "category_name": "Employment Agreement", "company_name": "Gene Logic Inc", "created": "August 9th, 2002", "published": true, "pretty": null, "uri": "/contracts/52NWcFzkv9l", "title": "EMPLOYMENT AGREEMENT", "group_id": "52NWcFzkv9l", "group_samples": [{"label": "Employment Agreement (Gene Logic Inc)", "uri": "/contracts/52NWcFzkv9l", "published": true}], "group_size": 1, "tags": [{"name": "Employment Agreement", "type": "category", "uri": "/contracts/tagged/employment-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}]}, {"intro": "This amendment is made as of the 1st day of January 2008 (the \u201cAmendment Effective Date\u201d) by and between Ore Pharmaceuticals Inc. (formerly Gene Logic Inc.,) a Delaware corporation (the \u201cCompany\u201d), and Larry Tiffany (\u201cExecutive\u201d).\n", "id": "5QZDNUT7Isa", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000115752308003494/a5673230ex10_93d.htm", "category_name": "Executive Employment Agreement", "company_name": "Gene Logic Inc", "created": "April 30th, 2008", "published": true, "pretty": null, "uri": "/contracts/5QZDNUT7Isa", "title": "First Amendment to Executive Employment Agreement with Larry Tiffany", "group_id": "5QZDNUT7Isa", "group_samples": [{"label": "Executive Employment Agreement (Gene Logic Inc)", "uri": "/contracts/5QZDNUT7Isa", "published": true}], "group_size": 1, "tags": [{"name": "Executive Employment Agreement", "type": "category", "uri": "/contracts/tagged/executive-employment-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}]}, {"intro": "", "id": "6F2zSAVB1e0", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000115752306002756/a5098035ex10_91.htm", "category_name": "Xenogen License Agreement", "company_name": "Gene Logic Inc", "created": "March 16th, 2006", "published": true, "pretty": null, "uri": "/contracts/6F2zSAVB1e0", "title": "Contract", "group_id": "6F2zSAVB1e0", "group_samples": [{"label": "Xenogen License Agreement (Gene Logic Inc)", "uri": "/contracts/6F2zSAVB1e0", "published": true}], "group_size": 1, "tags": [{"name": "Xenogen License Agreement", "type": "category", "uri": "/contracts/tagged/xenogen-license-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "California", "type": "jurisdiction", "uri": "/contracts/tagged/california-us"}]}, {"intro": "This Professional Services Agreement (\u201cAgreement\u201d) is entered into by Ore Pharmaceuticals Inc. (\u201cOre\u201d) having an address at 610 Professional Drive, Suite 101, Gaithersburg, MD 20879 and Dudley Staples, (\u201cConsultant\u201d) having an address at 9806 Mahogany Run, Ijamsville, MD 21754.", "id": "6IP27J8SiGc", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000115752309003967/a5964878ex10_108.htm", "category_name": "Professional Services Agreement", "company_name": "Gene Logic Inc", "created": "May 15th, 2009", "published": true, "pretty": null, "uri": "/contracts/6IP27J8SiGc", "title": "Professional Services Agreement", "group_id": "6IP27J8SiGc", "group_samples": [{"label": "Professional Services Agreement (Gene Logic Inc)", "uri": "/contracts/6IP27J8SiGc", "published": true}], "group_size": 1, "tags": [{"name": "Professional Services Agreement", "type": "category", "uri": "/contracts/tagged/professional-services-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Maryland", "type": "jurisdiction", "uri": "/contracts/tagged/maryland-us"}]}, {"intro": "THIS SECURITY AGREEMENT (the \u201cAgreement\u201d) is effective as of the 15th day of June, 2009 (the \u201cEffective Date\u201d), between Ore Pharmaceuticals Inc., a Delaware corporation and its successors and assigns (\u201cOre\u201d), and Ocimum Biosolutions Inc., a Delaware corporation (\u201cOcimum\u201d and, together with Ore, the \u201cParties\u201d).", "id": "6Q8lrwadNst", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000115752309004646/a5996995ex10112.htm", "category_name": "Security Agreement", "company_name": "Gene Logic Inc", "created": "June 29th, 2009", "published": true, "pretty": null, "uri": "/contracts/6Q8lrwadNst", "title": "SECURITY AGREEMENT", "group_id": "6Q8lrwadNst", "group_samples": [{"label": "Security Agreement (Gene Logic Inc)", "uri": "/contracts/6Q8lrwadNst", "published": true}], "group_size": 1, "tags": [{"name": "Security Agreement", "type": "category", "uri": "/contracts/tagged/security-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Maryland", "type": "jurisdiction", "uri": "/contracts/tagged/maryland-us"}]}, {"intro": "THIS EMPLOYMENT AGREEMENT is entered into on the 7th day of June, 2001 (the \u201cEffective Date\u201d), by and between Gene Logic Inc., a Delaware corporation (the \u201cCompany\u201d), and Michael J. Brennan (the \u201cExecutive\u201d).", "id": "6VsPGUlI0K1", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000095013302001254/w58282ex10-12.htm", "category_name": "Employment Agreement", "company_name": "Gene Logic Inc", "created": "March 28th, 2002", "published": true, "pretty": null, "uri": "/contracts/6VsPGUlI0K1", "title": "EMPLOYMENT AGREEMENT", "group_id": "6VsPGUlI0K1", "group_samples": [{"label": "Employment Agreement (Gene Logic Inc)", "uri": "/contracts/6VsPGUlI0K1", "published": true}], "group_size": 1, "tags": [{"name": "Employment Agreement", "type": "category", "uri": "/contracts/tagged/employment-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Maryland", "type": "jurisdiction", "uri": "/contracts/tagged/maryland-us"}]}, {"intro": "This Service Provider Agreement (the \"Agreement\") is entered into as of 01/01/2007 (the \"Effective Date\") by and between Affymetrix, Inc., having its principal place of business at 3420 Central Expressway, Santa Clara, CA 95051 (\"Affymetrix\") and Gene Logic Inc., having its principal place of business at 50 West Watkins Mill Road, Gaithersburg, MD, 20878, USA, (\"Service Provider\"), each a \"Party,\" and together the \"Parties\" to this Agreement.", "id": "6XRQTqWu9rd", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000115752307004994/a5398525ex10_50d.htm", "category_name": "Service Provider Agreement", "company_name": "Gene Logic Inc", "created": "May 10th, 2007", "published": true, "pretty": null, "uri": "/contracts/6XRQTqWu9rd", "title": "Service Provider Agreement", "group_id": "6XRQTqWu9rd", "group_samples": [{"label": "Service Provider Agreement (Gene Logic Inc)", "uri": "/contracts/6XRQTqWu9rd", "published": true}], "group_size": 1, "tags": [{"name": "Service Provider Agreement", "type": "category", "uri": "/contracts/tagged/service-provider-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "California", "type": "jurisdiction", "uri": "/contracts/tagged/california-us"}]}, {"intro": "", "id": "70C2wnkCrs4", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000091205797032791/29.txt", "category_name": "Share Purchase Agreement", "company_name": "Gene Logic Inc", "created": "October 7th, 1997", "published": true, "pretty": null, "uri": "/contracts/70C2wnkCrs4", "title": "GENE LOGIC INC. AND JAPAN TOBACCO INC. SHARE PURCHASE AGREEMENT SEPTEMBER 9, 1997", "group_id": "70C2wnkCrs4", "group_samples": [{"label": "Share Purchase Agreement (Gene Logic Inc)", "uri": "/contracts/70C2wnkCrs4", "published": true}], "group_size": 1, "tags": [{"name": "Share Purchase Agreement", "type": "category", "uri": "/contracts/tagged/share-purchase-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "Delaware", "type": "jurisdiction", "uri": "/contracts/tagged/delaware-us"}]}, {"intro": "THIS EMPLOYMENT AGREEMENT (the \u201cAgreement\u201d) is entered into as of the 1st day of April, 2003, by and between Gene Logic Inc., a Delaware corporation (the \u201cCompany\u201d), and Stephen J. Trevisan (the \u201cExecutive\u201d).", "id": "7poswwBqNpj", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000095013303001232/w85156exv10w77.htm", "category_name": "Employment Agreement", "company_name": "Gene Logic Inc", "created": "April 3rd, 2003", "published": true, "pretty": null, "uri": "/contracts/7poswwBqNpj", "title": "EMPLOYMENT AGREEMENT", "group_id": "7poswwBqNpj", "group_samples": [{"label": "Employment Agreement (Gene Logic Inc)", "uri": "/contracts/7poswwBqNpj", "published": true}], "group_size": 1, "tags": [{"name": "Employment Agreement", "type": "category", "uri": "/contracts/tagged/employment-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Maryland", "type": "jurisdiction", "uri": "/contracts/tagged/maryland-us"}]}, {"intro": "THIS UNCONDITIONAL GUARANTY AGREEMENT (this \u201cAgreement\u201d) is effective as of the 15th day of June, 2009, between CORAMANDEL INFRASTRUCTURE PRIVATE LIMITED, a company incorporated under the Company Act, 1956, in the Republic of India (the \u201cGuarantor\u201d), in favor of ORE PHARMACEUTICALS INC., a Delaware corporation, any successor holder of the Note described below, and all successors and assigns of any of the foregoing (collectively, \u201cOre\u201d).", "id": "7xPwvQ5hmKL", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000115752309004646/a5996995ex10113.htm", "category_name": "Unconditional Guarantee Agreement", "company_name": "Gene Logic Inc", "created": "June 29th, 2009", "published": true, "pretty": null, "uri": "/contracts/7xPwvQ5hmKL", "title": "UNCONDITIONAL GUARANTEE AGREEMENT", "group_id": "7xPwvQ5hmKL", "group_samples": [{"label": "Unconditional Guarantee Agreement (Gene Logic Inc)", "uri": "/contracts/7xPwvQ5hmKL", "published": true}], "group_size": 1, "tags": [{"name": "Unconditional Guarantee Agreement", "type": "category", "uri": "/contracts/tagged/unconditional-guarantee-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Maryland", "type": "jurisdiction", "uri": "/contracts/tagged/maryland-us"}]}, {"intro": "", "id": "8tJUsbOVi8s", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000095013303001232/w85156exv2w1.htm", "category_name": "Merger Agreement", "company_name": "Gene Logic Inc", "created": "April 3rd, 2003", "published": true, "pretty": null, "uri": "/contracts/8tJUsbOVi8s", "title": "AGREEMENT AND PLAN OF MERGER AMONG GENE LOGIC INC. THERIMMUNE RESEARCH CORPORATION, GLA II CORP. AND EDWARD J. KRAUSE, III as Securityholders\u2019 Representative DATED FEBRUARY 25, 2003", "group_id": "8tJUsbOVi8s", "group_samples": [{"label": "Merger Agreement (Gene Logic Inc)", "uri": "/contracts/8tJUsbOVi8s", "published": true}], "group_size": 1, "tags": [{"name": "Merger Agreement", "type": "category", "uri": "/contracts/tagged/merger-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Maryland", "type": "jurisdiction", "uri": "/contracts/tagged/maryland-us"}]}, {"intro": "In connection with the change in circumstances of Company, Parent and Purchaser since the time of the execution of the APA, the Parties wish to, and hereby do, amend the APA as provided below. Capitalized terms used herein, but not otherwise defined herein, shall have the meanings given to such terms in the APA.", "id": "93qcWximR0e", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000115752307012272/a5570624ex1099a.htm", "category_name": "Asset Purchase Agreement", "company_name": "Gene Logic Inc", "created": "December 18th, 2007", "published": true, "pretty": null, "uri": "/contracts/93qcWximR0e", "title": "December 12, 2007", "group_id": "93qcWximR0e", "group_samples": [{"label": "Asset Purchase Agreement (Gene Logic Inc)", "uri": "/contracts/93qcWximR0e", "published": true}], "group_size": 1, "tags": [{"name": "Asset Purchase Agreement", "type": "category", "uri": "/contracts/tagged/asset-purchase-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}]}, {"intro": "", "id": "9kgOvUPig5j", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000091205797032791/16.txt", "category_name": "Employment Agreement", "company_name": "Gene Logic Inc", "created": "October 7th, 1997", "published": true, "pretty": null, "uri": "/contracts/9kgOvUPig5j", "title": "Exhibit 10.12 EMPLOYMENT AGREEMENT", "group_id": "9kgOvUPig5j", "group_samples": [{"label": "Employment Agreement (Gene Logic Inc)", "uri": "/contracts/9kgOvUPig5j", "published": true}], "group_size": 1, "tags": [{"name": "Employment Agreement", "type": "category", "uri": "/contracts/tagged/employment-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}]}, {"intro": "", "id": "9rQyZmflyPl", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000104746998012882/1.txt", "category_name": "Genomic Database Collaboration and License Agreement", "company_name": "Gene Logic Inc", "created": "March 31st, 1998", "published": true, "pretty": null, "uri": "/contracts/9rQyZmflyPl", "title": "WITNESSETH:", "group_id": "9rQyZmflyPl", "group_samples": [{"label": "Genomic Database Collaboration and License Agreement (Gene Logic Inc)", "uri": "/contracts/9rQyZmflyPl", "published": true}], "group_size": 1, "tags": [{"name": "Genomic Database Collaboration and License Agreement", "type": "category", "uri": "/contracts/tagged/genomic-database-collaboration-and-license-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "Services-commercial physical & biological research", "type": "industry", "uri": "/contracts/tagged/services-commercial-physical-biological-research"}, {"name": "Maryland", "type": "jurisdiction", "uri": "/contracts/tagged/maryland-us"}]}, {"intro": "THIS RELEASE OF FURTHER PERFORMANCE UNDER LEASE (this \u201cRelease\u201d) is entered into as of the Thirty-first day of July, 2009 (\u201cEffective Date\u201d), by and between 50 WEST WATKINS MILL ROAD, LLC, a Delaware limited liability company (f/k/a ARE-50 West Watkins Mill, LLC) (\u201cLandlord\u201d), and ORE PHARMACEUTICALS INC., a Delaware corporation (f/k/a Gene Logic Inc.) (\u201cOriginal Tenant\u201d).", "id": "9s7O6uP90Vw", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000115752309005742/a6024452ex10_115.htm", "category_name": "Release of Further Performance Under Lease", "company_name": "Ore Pharmaceuticals Inc.", "created": "August 6th, 2009", "published": true, "pretty": null, "uri": "/contracts/9s7O6uP90Vw", "title": "RELEASE OF FURTHER PERFORMANCE UNDER LEASE", "group_id": "9s7O6uP90Vw", "group_samples": [{"label": "Release of Further Performance Under Lease (Ore Pharmaceuticals Inc.)", "uri": "/contracts/9s7O6uP90Vw", "published": true}], "group_size": 1, "tags": [{"name": "Release of Further Performance Under Lease", "type": "category", "uri": "/contracts/tagged/release-of-further-performance-under-lease"}, {"name": "Ore Pharmaceuticals Inc.", "type": "company", "uri": "/company/1043914/ore-pharmaceuticals-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Maryland", "type": "jurisdiction", "uri": "/contracts/tagged/maryland-us"}]}, {"intro": "", "id": "9uk3LFcsaRv", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000091205797032791/32.txt", "category_name": "Sole Commercial Patent License Agreement", "company_name": "Gene Logic Inc", "created": "October 7th, 1997", "published": true, "pretty": null, "uri": "/contracts/9uk3LFcsaRv", "title": "Confidential Treatment Requested Under 17 C.F.R. Sections 200.80 (b)(4), 200.83 and 230.406 ***Indicates omitted material that is the subject of a confidential treatment request filed separately with the Commission. SOLE COMMERCIAL PATENT LICENSE...", "group_id": "9uk3LFcsaRv", "group_samples": [{"label": "Sole Commercial Patent License Agreement (Gene Logic Inc)", "uri": "/contracts/9uk3LFcsaRv", "published": true}], "group_size": 1, "tags": [{"name": "Sole Commercial Patent License Agreement", "type": "category", "uri": "/contracts/tagged/sole-commercial-patent-license-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "Tennessee", "type": "jurisdiction", "uri": "/contracts/tagged/tennessee-us"}]}, {"intro": "THIS EMPLOYMENT AGREEMENT (the \u201cAgreement\u201d) is entered into as of the 23th day of July, 2007 by and between Gene Logic Inc., a Delaware corporation (the \u201cCompany\u201d), and Stephen Donahue, M.D. (the \u201cExecutive\u201d).", "id": "Ca9XBb8Zd0", "source_url": "https://www.sec.gov/Archives/edgar/data/1043914/000115752309003967/a5964878ex10_109.htm", "category_name": "Executive Employment Agreement", "company_name": "Gene Logic Inc", "created": "May 15th, 2009", "published": true, "pretty": null, "uri": "/contracts/Ca9XBb8Zd0", "title": "EXECUTIVE EMPLOYMENT AGREEMENT", "group_id": "Ca9XBb8Zd0", "group_samples": [{"label": "Executive Employment Agreement (Gene Logic Inc)", "uri": "/contracts/Ca9XBb8Zd0", "published": true}], "group_size": 1, "tags": [{"name": "Executive Employment Agreement", "type": "category", "uri": "/contracts/tagged/executive-employment-agreement"}, {"name": "Gene Logic Inc", "type": "company", "uri": "/company/1043914/gene-logic-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Maryland", "type": "jurisdiction", "uri": "/contracts/tagged/maryland-us"}]}], "next_curs": "CjAKEAoKZ3JvdXBfc2l6ZRICCAEKGAoIZ3JvdXBfaWQSDBoKQ2E5WEJiOFpkMBgAIAE=", "cursor": "CjEKEAoKZ3JvdXBfc2l6ZRICCAUKGQoIZ3JvdXBfaWQSDRoLMTY3ZTc0MkY4N1YYACAB"}}